Atlas Trials

Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine Transdermal Patch in Healthy Chinese Subjects

Clinical trial NCT01675024 · COMPLETED

Trial details

NCT number
NCT01675024
Sponsor
UCB Pharma
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2012-08-01
Primary completion
2012-09-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.